Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological database.
Casarotto E, Chandwani S, Mortier L, Dereure O, Dutriaux C, Dalac S, Scherrer E, Lévy-Bachelot L, Verdoni L, Farge G, Allayous C, Oriano B, Dalle S, Lebbé C. Casarotto E, et al. Among authors: lebbe c. Immunotherapy. 2021 Aug;13(11):905-916. doi: 10.2217/imt-2021-0077. Epub 2021 Jun 2. Immunotherapy. 2021. PMID: 34074114 Free article.
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.
Kérob D, Porcher R, Vérola O, Dalle S, Maubec E, Aubin F, D'Incan M, Bodokh I, Boulinguez S, Madelaine-Chambrin I, Mathieu-Boue A, Servant JM, de Kerviler E, Janin A, Calvo F, Pedeutour F, Lebbe C. Kérob D, et al. Among authors: lebbe c. Clin Cancer Res. 2010 Jun 15;16(12):3288-95. doi: 10.1158/1078-0432.CCR-09-3401. Epub 2010 May 3. Clin Cancer Res. 2010. PMID: 20439456 Free article. Clinical Trial.
Syringotropic mycosis fungoides: clinical and histologic features, response to treatment, and outcome in 19 patients.
de Masson A, Battistella M, Vignon-Pennamen MD, Cavelier-Balloy B, Mouly F, Rybojad M, Bouaziz JD, Petit A, Saussine A, Ronceray S, Le Gall F, Ram-Wolff C, Assouly P, Dereure O, Joly P, Dallot A, Dupuy A, Lebbé C, Moulonguet I, Rivet J, Janin A, Bagot M. de Masson A, et al. Among authors: lebbe c. J Am Acad Dermatol. 2014 Nov;71(5):926-34. doi: 10.1016/j.jaad.2014.06.033. Epub 2014 Jul 18. J Am Acad Dermatol. 2014. PMID: 25044343
Nivolumab in previously untreated melanoma without BRAF mutation.
Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebbé C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Arance A, Schmidt H, Schadendorf D, Gogas H, Lundgren-Eriksson L, Horak C, Sharkey B, Waxman IM, Atkinson V, Ascierto PA. Robert C, et al. Among authors: lebbe c. N Engl J Med. 2015 Jan 22;372(4):320-30. doi: 10.1056/NEJMoa1412082. Epub 2014 Nov 16. N Engl J Med. 2015. PMID: 25399552 Free article. Clinical Trial.
Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids.
Chasset F, Pages C, Biard L, Roux J, Sidina I, Madelaine I, Basset-Seguin N, Viguier M, Madjlessi-EzrA N, Schneider P, Bagot M, Resche-Rigon M, Lebbe C. Chasset F, et al. Among authors: lebbe c. Eur J Dermatol. 2015 Jan-Feb;25(1):36-44. doi: 10.1684/ejd.2014.2471. Eur J Dermatol. 2015. PMID: 25500362
579 results